Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study
2012 ◽
Vol 60
(17)
◽
pp. B158-B159
2013 ◽
Vol 82
(7)
◽
pp. E856-E863
◽
Keyword(s):
2012 ◽
Vol 11
(3)
◽
pp. 152-159
◽
2011 ◽
Vol 12
(4)
◽
pp. 220-227
◽
2014 ◽
Vol 29
(1)
◽
pp. 66
◽